A recent study by Castellani et al. (JAMA 302(23):2573–2579, 2009) describes the population-level effects of the choices of individuals who underwent molecular carrier screening for cystic fibrosis (CF) in Veneto, in the northeastern part of Italy, between 1993 and 2007. We discuss some of the ethical issues raised by the policies and individual choices that are the subject of this study. In particular, (1) we discuss the ethical issues raised by the acquisition of genetic information through antenatal carrier testing; (2) we consider whether by choosing to procreate naturally these couples can harm the resulting child and/or other members of society, and what the moral implications of such harm would be; (3) we consider whether by choosing to avoid natural procreation carrier couples can harm current or future individuals affected by cystic fibrosis; (4) we discuss whether programs that make carrier testing available can be considered eugenic programs.
Cystic fibrosis carrier screening in Veneto (Italy) : an ethical analysis / T. Bruni, M. Mameli, G. Pravettoni, G. Boniolo. - In: MEDICINE, HEALTH CARE AND PHILOSOPHY. - ISSN 1386-7423. - 15:3(2012), pp. 321-328. [10.1007/s11019-011-9347-7]
Cystic fibrosis carrier screening in Veneto (Italy) : an ethical analysis
T. BruniPrimo
;G. PravettoniPenultimo
;G. BonioloUltimo
2012
Abstract
A recent study by Castellani et al. (JAMA 302(23):2573–2579, 2009) describes the population-level effects of the choices of individuals who underwent molecular carrier screening for cystic fibrosis (CF) in Veneto, in the northeastern part of Italy, between 1993 and 2007. We discuss some of the ethical issues raised by the policies and individual choices that are the subject of this study. In particular, (1) we discuss the ethical issues raised by the acquisition of genetic information through antenatal carrier testing; (2) we consider whether by choosing to procreate naturally these couples can harm the resulting child and/or other members of society, and what the moral implications of such harm would be; (3) we consider whether by choosing to avoid natural procreation carrier couples can harm current or future individuals affected by cystic fibrosis; (4) we discuss whether programs that make carrier testing available can be considered eugenic programs.File | Dimensione | Formato | |
---|---|---|---|
Cystic.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
178.84 kB
Formato
Adobe PDF
|
178.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.